Biotest vz. Aktie
WKN: 522723 / ISIN: DE0005227235
11.01.2024 17:34:43
|
EQS-AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Biotest AG
/ Preliminary announcement on the disclosure of financial statements
Biotest AG hereby announces that the following financial reports shall be disclosed for the business year 2023:
Report Type: Annual financial report Language: German Date of disclosure: March 28, 2024 Address: https://www.biotest.com/de/de/investor_relations/news_und_publikationen_/publikationen/geschaeftsberichte.cfm Language: English Date of disclosure: March 28, 2024 Address: https://www.biotest.com/de/en/investor_relations/news_and_publications/publications/annual_reports.cfm Report Type: Annual financial report of the group Language: German Date of disclosure: March 28, 2024 Address: https://www.biotest.com/de/de/investor_relations/news_und_publikationen_/publikationen/geschaeftsberichte.cfm Language: English Date of disclosure: March 28, 2024 Address: https://www.biotest.com/de/en/investor_relations/news_and_publications/publications/annual_reports.cfm
11.01.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Biotest AG |
Landsteinerstraße 5 | |
63303 Dreieich | |
Germany | |
Internet: | www.biotest.de |
End of News | EQS News Service |
|
1813427 11.01.2024 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biotest AG Vz.mehr Nachrichten
03.06.25 |
EQS-Adhoc: Biotest AG: Delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6 June 2025 (EQS Group) | |
03.06.25 |
EQS-Adhoc: Biotest AG: Delisting der Biotest-Aktien von der Frankfurter Wertpapierbörse mit Ablauf des 6. Juni 2025 (EQS Group) | |
28.05.25 |
EQS-Adhoc: Biotest AG: Wechsel des Chief Executive Officer (CEO) der Biotest AG (EQS Group) | |
28.05.25 |
EQS-Adhoc: Biotest AG: Change of the Chief Executive Officer (CEO) of Biotest AG (EQS Group) | |
12.05.25 |
EQS-News: Biotest confirms Guidance for 2025 (EQS Group) | |
12.05.25 |
EQS-News: Biotest bestätigt die Prognose für das Jahr 2025 (EQS Group) | |
31.03.25 |
EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer (EQS Group) | |
31.03.25 |
EQS-Adhoc: Biotest AG: Delisting-Vereinbarung und angekündigtes Delisting-Erwerbsangebot (EQS Group) |
Analysen zu Biotest AG Vz.mehr Analysen
Aktien in diesem Artikel
Biotest AG Vz. | 29,20 | -2,01% |
|